NEW YORK – Codexis announced Monday an agreement to license its EvoT4 DNA ligase enzyme to Roche.
The firm said it expects Roche to incorporate the enzyme in next-generation sequencing library preparation kits and other sequencing products.
Under the terms of the license, Roche gained worldwide rights to include EvoT4 DNA ligase in its nucleic acid sequencing products and workflows. Roche will pay Codexis royalties; other financial details were not disclosed.